Medicine and Dentistry
Lung Tuberculosis
100%
Prognostic Factor
78%
Lung
77%
Computer Assisted Tomography
70%
Hazard Ratio
52%
Non Small Cell Lung Cancer
52%
Lung Cancer
50%
Odds Ratio
44%
Disease
41%
Silo-Filler's Disease
39%
Artificial Respiration
38%
Lung Adenocarcinoma
34%
Clinical Feature
33%
Idiopathic Interstitial Pneumonia
29%
Diagnosis
26%
Stenosis
26%
Acute Respiratory Distress Syndrome
25%
Asthma
25%
Atypical Mycobacterium
24%
Retrospective Cohort Study
22%
Pulmonary Embolism
22%
Chronic Obstructive Pulmonary Disease
22%
Stenting
22%
Lung Nodule
21%
Primary Tumor
21%
Dyspnea
20%
Body Mass Index
20%
Epidermal Growth Factor Receptor
19%
Influenza A (H1N1)
19%
Tuberculosis Treatment
19%
Levofloxacin
19%
Multidrug Resistant Tuberculosis
19%
Sputum
19%
Elderly Patient
19%
Malignant Neoplasm
18%
Patient Referral
18%
Lung Biopsy
18%
Bronchial Artery
17%
Thorax Radiography
17%
Pathogen
16%
Forced Expiratory Volume
16%
Low Drug Dose
15%
Bronchoscopy
15%
Arterial Embolization
14%
Transthoracic Biopsy
14%
Hospital Mortality
14%
Infection
14%
Biopsy Technique
14%
Sputum Culture
14%
Proportional Hazards Model
14%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Tuberculosis
73%
Non Small Cell Lung Cancer
45%
Clinical Feature
35%
Asthma
35%
Acute Respiratory Failure
34%
Chronic Obstructive Lung Disease
32%
Disease
31%
Lung Adenocarcinoma
29%
Lung Cancer
28%
Gefitinib
26%
Erlotinib
26%
Epidermal Growth Factor Receptor
22%
Prevalence
20%
Epidermal Growth Factor Receptor Kinase Inhibitor
20%
Lung Disease
19%
Community Acquired Pneumonia
19%
Levofloxacin
19%
Hemoptysis
18%
Malignant Neoplasm
15%
Hospital Mortality
14%
Interleukin 2
14%
Atypical Mycobacterium
13%
Tuberculosis
13%
Coughing
13%
Tuberculostatic Agent
11%
Influenza A (H1N1)
11%
Cohort Study
10%
Pleura Effusion
10%
Syndrome
10%
Atelectasis
10%
Allergic Reaction
9%
Reflux Esophagitis
9%
Influenza A Virus (H1N1)
9%
Toll Like Receptor 2
9%
Prospective Study
9%
Observational Study
9%
Paclitaxel
9%
Small Cell Lung Cancer
9%
Fibrosing Alveolitis
9%
CYP2E1
9%
Antivirus Agent
9%
Spontaneous Pneumothorax
9%
Loeffler Pneumonia
9%
Virus Infection
9%
Femur Fracture
9%
Chest Infection
9%
Adult Respiratory Distress Syndrome
9%
Cytokine
9%
Hepatotoxicity
9%
Cidofovir
9%
Nursing and Health Professions
Confidence Interval
53%
Intensive Care Unit
39%
Odds Ratio
27%
Obstructive Lung Disease
24%
Non Small Cell Lung Cancer
24%
Hazard Ratio
23%
Body Mass
20%
Lung Cancer
19%
Artificial Respiration
19%
Elderly Patient
15%
Tertiary Care Center
13%
Forced Expiratory Volume
10%
Clinical Outcome
10%
Clinical Feature
10%
Pandemic Influenza
9%
Tidal Volume
9%
Long Term Care
9%
Grip Strength
9%
Fibrosing Alveolitis
9%
Adult Respiratory Distress Syndrome
9%
Infection
9%
Prevalence
9%
Influenza A (H1N1)
9%
Femur Fracture
9%
Systolic Blood Pressure
9%
Acute Cholecystitis
9%
Cancer Therapy
7%
Hospital Mortality
7%
Proportional Hazards Model
7%
Intensive Care
5%
Asthma
5%
